🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Studies on Adsorption International Learning Initiative Global

RecruitingNAAges 18 Years - anyAllBotkin Hospital
NCT07123909 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Use of sorption technologies in patients undergoing maintenance hemodialysis with inflammatory syndrome and clinical manifestations of uremia

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Adequate dialysis defined by a KT/V index ≥ 1.4 2. No active inflammatory process or infection 3. Age ≥ 18 years 4. Receiving standard hemodialysis regimen three times weekly, at least 4 hours per session 5. Participants with elevated interleukin-6 (IL-6) and/or C-reactive protein (CRP) levels exceeding local laboratory reference values Exclusion Criteria: 1. Current use of steroids or immunosuppressive therapy 2. History of kidney transplantation 3. Diagnosis of cancer 4. Pregnancy
💊

What it tests

  • Patients will undergo a combined hemodialysis and hemosorption procedure. The study cartridge for hemosorption by Jafron HA130 contains the original adsorbing material.
📍

Where

1 site
Botkin Hospital
Moscow, Russia
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy